Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

Hannah Linden, MD, Highlights AMEERA-1 Data for ER+/HER2- Metastatic Breast Cancer

Dr Linden, Seattle Cancer Care Alliance, Seattle, WA,  shares encouraging results from the AMEERA-1 trial of SAR439859, an oral estrogen receptor degrader, for ER+/HER2- metastatic breast cancer, presented at the virtual SABCS Annual Meeting.

Advertisement

Advertisement

Advertisement

Advertisement